Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

NCT07567742 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Oral Mucositis (Ulcerative) Due to Radiation
Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Taurine

Sponsor

Sun Yat-sen University